当前位置: 首页 > 期刊 > 《风湿病与关节炎》 > 2019年第11期
编号:13443124
Wnt/β-catenin拮抗剂DKK-1在强直性脊柱炎中的研究进展(5)
http://www.100md.com 2019年11月1日 《风湿病与关节炎》 2019年第11期
     [34] SAKELLARIOU GT,ILIOPOULOS A,KONSTA M,et al.

    Serum levels of Dkk-1,sclerostin and VEGF in patients with ankylosing spondylitis and their association with smoking,and clinical,inflammatory and radiographic parameters[J].Joint Bone Spine,2017,84(3):309-315.

    [35] NIU CC,LIN SS,YUAN LJ,et al.Correlation of blood bone turnover biomarkers and Wnt signaling antagonists with AS,DISH,OPLL,and OYL[J].BMC Musculoskelet Disord,2017,18(1):61.

    [36] VAN DER HEIJDE D,LANDEWE R.Selection of a method for scoring radiographs for ankylosing spondylitis clinical trials, by the Assessment in Ankylosing Spondylitis Working Group and OMERACT[J].J Rheumatol,2005,32(10):2048-2049.

    [37] CREEMERS MC,FRANSSEN MJ,VAN'T HOF MA,et al.

    Assessment of outcome in ankylosing spondylitis:an extended radiographic scoring system[J].Ann Rheum Dis,2005,64(1):127-129.

    [38] 孔维萍,周童亮,王晓曈,等.补肾强督方对强直性脊柱炎患者Dickkopf1蛋白水平的影响[J].中医杂志,2014,55(20):1750-1753.

    [39] 苏小军,王海东,田雪梅.五劳七损方对强直性脊柱炎患者Dickkopf-1蛋白水平的影响[J].中国中医骨伤科杂志,2016,24(3):26-28.

    [40] 游济洲,周祖山,周艳华.三四祛痹汤与柳氮磺胺吡啶联合治疗强直性脊柱炎临床疗效及对血清IL-4、IL-18、Dickkopf1蛋白水平的影響[J].现代中西医结合杂志,2018,27(25):2797-2800.

    收稿日期:2019-07-26;修回日期:2019-09-18, http://www.100md.com(蔡鑫 唐芳 马武开 蒋总 樊梅 金泽旭)
上一页1 2 3 4 5